Published: 11 November 2021
Author(s): Paula Jiménez-Fonseca, Ramón Salazar, Vicent Valentí, Alberto Carmona-Bayonas, Giancarlo Agnelli
Issue: March 2022

Systems tend toward inertia until an external pressure pushes them toward change; thus, a situation of crisis such as the COVID-19 pandemic represents an opportunity for technological innovation. The prevailing need for treatments and vaccines has impelled innovation in the world of randomized clinical trials (RCT), resorting to ideas that had been floating around for a while. Is this merely a circumstantial phenomenon or are new methods here to stay?

Newsletters

Stay informed on our latest news!